Funds and ETFs Vivos Therapeutics, Inc.

Equities

VVOS

US92859E2072

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 02:00:01 27/04/2024 am IST 5-day change 1st Jan Change
2.59 USD +5.28% Intraday chart for Vivos Therapeutics, Inc. -4.78% -79.18%
Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization of a suit of diagnostic and multi-disciplinary treatment modalities for patients with cranial and/or dentofacial abnormalities and an array of medical conditions, including mild to moderate obstructive sleep apnea (OSA) and snoring in adults. The Company's Vivos Method is a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities and/or mild to moderate OSA and snoring. The Company's program is to train dentists and offer them other value-added services in connection with their ordering and use of the Vivos System for patients is called the Vivos Integrated Practice program. The Vivos Method comprises of various products and services, such as Vivos Complete Airway Repositioning and/or Expansion (CARE) oral appliance therapy; VivosGuides; Vivos Versa; POD and Night Block, and VivosMyoCorrect.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.59 USD
Average target price
7.225 USD
Spread / Average Target
+178.96%
Consensus
  1. Stock Market
  2. Equities
  3. VVOS Stock
  4. Funds and ETFs Vivos Therapeutics, Inc.